Doctor Markus Riederer
Idorsia Pharmaceuticals Ltd., Allschwil (Switzerland)
Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis
Event: ESC Congress 2020
Topic: Thrombosis, Bleeding
Session: Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction
ESC 365 is supported by
